Context
- Recently, Vice President of India launched the India Valve Registry at India Valves 2026 in Chennai.
- The initiative seeks to strengthen India-specific clinical evidence for the treatment of valvular and structural heart diseases.
What is the India Valve Registry?
- A collaborative multicentre initiative for systematic collection of real-world clinical data.
- Focuses on transcatheter valve interventions performed across India.
- Data will be collected in a systematic, secure and de-identified manner.
- Aims to convert individual clinical experiences into collective medical knowledge.
Why is it Significant?
- India-specific evidence: Reduces dependence on clinical evidence generated primarily in other countries.
- Real-world data: Helps assess outcomes beyond controlled clinical trials.
- Better healthcare: Enables doctors to learn from treatment outcomes and improve clinical practices.
- Research ecosystem: Strengthens collaboration among cardiologists, cardiac surgeons, researchers and healthcare institutions.
- Inclusive healthcare: Supports the broader goal of making advances in medical technology accessible to all.
About India Valves 2026
- India Valves 2026 is a national academic meeting on valvular and structural heart disease, bringing together leading cardiologists, cardiac surgeons, researchers and healthcare professionals from across the country and abroad for scientific exchange, training and collaborative research.
Conclusion
The India Valve Registry marks an important step towards building a stronger, evidence-based cardiovascular healthcare system in India. By generating India-specific real-world clinical evidence, it can improve treatment outcomes, support medical research and promote innovation in cardiac care. Ultimately, initiatives such as this can contribute to the vision of a “Viksit Bharat” that is also a “Swasth Bharat,” where advanced healthcare is accessible, inclusive and patient-centred.